Related Experiment Video
Updated: May 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Use of stents to treat extracranial cerebrovascular disease
Philip M Meyers1, H Christian Schumacher, Randall T Higashida
1Department of Radiology and Neurological Surgery, Columbia University, and Neuroendovascular Service, Neurological Institute of New York and New York Presbyterian Hospitals, New York, New York 10032, USA. pmm2002@columbia.edu
Insights
Stent-assisted carotid angioplasty with embolic filtration devices significantly reduces stroke risk compared to traditional methods. Ongoing trials compare this advanced technique to carotid endarterectomy for various patient groups.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Carotid endarterectomy (CEA) is the standard for significant carotid artery stenosis.
- Stent-assisted carotid angioplasty (CAS) is gaining traction for extracranial carotid artery disease.
Purpose of the Study:
- To review current advancements in CAS.
- To highlight the impact of embolic filtration devices (EFD) on CAS outcomes.
Main Methods:
- Review of current literature and clinical developments in CAS.
- Discussion of randomized multicenter trials comparing CAS with EFD to CEA.
Main Results:
- Embolic filtration devices (EFD) have substantially decreased periprocedural stroke rates in CAS.
- Ongoing trials are evaluating CAS with EFD against CEA in high-risk and asymptomatic patients.
Conclusions:
- CAS with EFD represents a significant evolution in treating carotid artery stenosis.
- Further research through ongoing trials will clarify the role of CAS with EFD in comparison to CEA.
Abstract:
Stent-assisted carotid angioplasty (CAS) is increasingly utilized for hemodynamically significant stenoses of the extracranial carotid artery. Carotid endarterectomy (CEA) is still considered the gold standard in the management of symptomatic hemodynamically significant carotid stenoses. However, endovascular device technology is rapidly evolving and the recent introduction of embolic filtration devices (EFD) proved to reduce periprocedural stroke rates in CAS considerably. Several randomized multicenter trials are currently recruiting patients to compare CAS with EFD to carotid endarterectomy in different cohorts, such as patients at high surgical risk for CEA and those with asymptomatic stenosis. The review presents current developments in CAS.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

